Navigation Links
Daytrana in Medical News

New analysis shows DAYTRANA offered ADHD symptom control for 12 months

Washington, D.C. May 7, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA (methylphenidate transdermal system) between boys and girls aged 6...

Long-term 12-month safety data on ADHD patch DAYTRANA

BOSTON OCTOBER 25, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRA...

Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom

DAYTRANA (methylphenidate transdermal system), formulated by Shire was the foremost patch medication approved to treat symptoms of ADHD in children//. Transdermal formulation of methylphenidate - DAYTRANA, is now available in pharmacies in varying doses such as 10 mg, 15 mg, 20 mg and 30 mg. ...

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced

.../recall of thirty-nine (39) lots of the ADHD patch daytrana (the lots of daytrana patches affected by this action are listed below). Shire is taking this action because some daytrana patches no longer meet their release liner removal...

Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track

... 10.6(3) n/a n/a 2% daytrana 9.4 -5% 64% ...to be recognized into revenue by the end of 2007. daytrana - ADHD DAYTRANA's average share of the US ADHD ma...the US ADHD market resulted in US prescriptions of daytrana for the three months to September 30, 2007 being u...

Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting

...e Effect Size in Children with ADHD Poster# E58 daytrana (methylphenidate transdermal system): October 25...Information go to http://www.vyvanse.com . About daytrana Tell your doctor about any heart conditions, incl...t heart problems, such as chest pain or fainting. daytrana should not be used if the child has: significant a...
Daytrana in Medical Technology

Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)

...m) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). A request from European regulators to conduct an additional clinical study on daytrana in a European patient population combined with the recently announced planned acquisition of the worldwide rights (excluding the US, Canada and Barbad...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

...D). The findings from the analysis reaffirmed that daytrana has an established safety profile and effectively ...n, D.C. "This analysis further demonstrates that daytrana has a recognized safety profile and is an effectiv... decreased weight. In the study, the efficacy of daytrana was measured using the ADHD Rating Scale (ADHD-RS-...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

...ractivity Disorder (ADHD) patch, demonstrated that daytrana provided significant ADHD tolerability and symptom...ective ADHD symptom control improvement when using daytrana for 12 months, improving their ability to maintain...a. "Importantly, this year- long study showed that daytrana maintained a favorable safety profile throughout t...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...ctivity Disorder APA Poster# NR750 daytrana (methylphenidate transdermal system): May 23...tite, insomnia, headache, and weight loss. About daytrana daytrana should not be used in patients with allergy to met...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

...D experienced effective ADHD treatment with use of daytrana for 12 months, sustaining the improvements in thei... Pittsburgh School of Medicine. "More importantly, daytrana maintained a favorable safety profile, meeting the... and other stimulants in this class." Shire's daytrana is the first and only patch medication approved by...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

...agnosed and, therefore, undertreated. Shire's daytrana is the first and only patch medication approved by...e symptoms of ADHD in children aged 6 to 12 years. daytrana is available in four dosage strengths - 10 mg, 15 ...dy's primary endpoint. The 58 boys that received daytrana averaged a significant 56 percent ADHD- RS-IV tota...
Daytrana in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 67.4 -77% -77% -48% 11.0% daytrana 14.9 -34% -34% ...ADDERALL XR to Teva in the URA calculation. daytrana - ADHD Product sales of daytrana for the three months to June 30, 2009 decreased by...

Shire begins the year with a strong performance

...-promotion of LIALDA in the US. Pipeline daytrana - for the treatment of ADHD in children in the EU ...he MAA does not impact Shire's commitment to daytrana in the US where the product has been used as...the US in the fourth quarter of 2009; - daytrana for the treatment of ADHD in adolescents in the US...

Publication of Shire plc's Annual Report 2008

...VANT in certain EU countries; - the launch of daytrana (EU and Canada); - the continued roll out of ...oval; six in the US (FOSRENOL and EQUETRO in 2004, daytrana and ELAPRASE in 2006, LIALDA and VYVANSE in 2007) ...atory filing for VYVANSE in Europe in 2010. daytrana for ADHD in EU & Canada Regulatory subm...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ucting additional clinical outcomes trials; - daytrana (methylphenidate transdermal system) for use in th... 318.9 +317% +388% 8.2% daytrana 78.7 +23% -11% ...n 2007) and a price increase in April 2008. daytrana - ADHD Product sales for the year to Decemb...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... 96.0 806% n/a 9.0% daytrana 18.1 93% -14% ... of 10.2%, based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Sep... of DAYTRANA. No interruption in the production of daytrana is anticipated. Shire and Noven may take additiona...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... 65.2 n/a n/a 7.4% daytrana 22.6 14% -11% ...re of 8.2% based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Jun...nounced a voluntary recall of a limited portion of daytrana patches because certain patches did not meet their...

Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced

...voluntary recall of two (2) lots of the ADHD patch daytrana (lots 2750211 and 2764111). Shire is taking this a...while being opened. The current supply levels of daytrana should be sufficient to ensure that patients can continue to have their daytrana prescriptions filled at their local pharmacy. Nove...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

...have difficulty removing the release liner of some daytrana patches, similar to the concerns which led to a voluntary market withdrawal of a limited number of daytrana patches in September 2007. Shire and Noven continu...for use in adult patients in the US in Q2 2008; - daytrana in the EU during H1 2009; - INTUNIV in the US dur...

Shire plc: IFRS Results for the Year Ending December 31, 2007

... 76.5 - N/A N/A daytrana 64.2 25.1 +156 +...to revenue during the year to December 31, 2007. daytrana - ADHD Product sales for the year to December 31...NA was launched in June 2006). US prescriptions of daytrana for the year to December 31, 2007 over 2006 benefi...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

...nto new geographies. These products, together with daytrana that was launched last year, represented 32% of ou... patients, of which 7.5 million are untreated. - daytrana - ADHD - Regulatory submissions were filed for app...US in Q2 2008 (PDUFA date April 28, 2008); - daytrana in the EU during H1 2009; - INTUNIV in the US dur...
Other Tags
(Date:7/12/2014)... "The second toes cross over the big toes ... shoes," said an inventor from East Hartford, Conn. This gave ... happening. , He then created a prototype of the Comfort ... and big toes from overlapping. This avoids discomfort and pain, ... easy to use, it's ideal for people with foot problems, ...
(Date:7/12/2014)... 12, 2014 Using and carrying around ... two inventors from Ashland, Va., decided that there needed ... inspired us to conceive of our design," he said. ... KIDNEY KOVER, which provides an inconspicuous way to use ... as well as promotes comfort and peace of mind. ...
(Date:7/12/2014)... July 12, 2014 For those who are ... can readily absorb the nutrients in food. The enzymes literally ... are small enough to be absorbed by human bodies. According ... lack of enzymes in regular food is the cause of ... that was started by Michelle DelPresto, a mother of 3 ...
(Date:7/12/2014)... Doylestown Hospital recently conducted an interview ... health questions. Paddock tackles topics including main men's ... live longer than men, and testosterone replacement therapy, among ... featured on Doylestown Hospital’s website, Dr. Brad Paddock ... age. If you notice pain, bulging, or asymmetry in ...
(Date:7/12/2014)... 2014 Dubai is buzzing with the ... heading to the UAE. The National Basketball Association’s ... in the UAE from 28-31 October to lead the ... diabetes awareness. The event is being organized by Maven ... management company based in Dubai. The announcement was made ...
Breaking Medicine News(10 mins):Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3
(Date:7/11/2014)... mesenchymal stem cells can stimulate neurogenesis in the brain ... (AD) and improve tissue and function injury under the ... the therapeutic effect of adipose-derived stem cells (ADSCs) transplantation ... oxidative injury and neurogenesis in the brain of AD ... Life Sciences, Tsinghua University, China transplanted ADSCs into the ...
(Date:7/11/2014)... toxins to study the proteins that let nerve cells ... have stumbled upon a biological tactic that may offer ... in a safe and environmentally responsible way. , ... for one species and harmless for a closely related ... pests without harming beneficial species like bees. A summary ...
(Date:7/10/2014)... BEDFORD, Mass. , June 30, 2014  Aware, ... of biometrics software and services, previously announced on June ... a special cash dividend of $1.75 per share, or ... record date of July 10, 2014 and a payment ... notified by NASDAQ that it had set an ex-dividend ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2
Other Contents